Clindamycin-Based 3D-Printed and Electrospun Coatings for Treatment of Implant-Related Infections
Overview
Affiliations
This study presents the development and characterisation of two novel bioactive coatings deposited on TiAlV and AISI 316LVM substrates. The coatings were prepared using 3D printing and electrospinning. The 3D-printed coating consisted of the cellulose nanofibril suspension, alginate, and carboxymethylcellulose (CMC), while CMC and polyethylene oxide were used to prepare the electrospun coating. Both coatings were loaded with the antibiotic clindamycin (CLIN), which is a bacteriostatic lincosamide known for its activity against streptococci, staphylococci, pneumococci, Bacteroides species, and other anaerobes. Initial characterisation of the coatings was performed by attenuated total reflectance Fourier transform infrared spectroscopy, field emission scanning electron microscopy, and atomic force microscopy. Furthermore, the contact angle measurements, swelling rate, and biodegradability of the coatings were investigated. The released concentration of CLIN in PBS (pH = 7.4 at 25 °C) was determined by UV-VIS spectrophotometry. The coatings' biocompatibility was determined using an MTT (3(4,5 dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay using an osteoblast cell culture (hFOB 1.19, ATCC CRL 11372).
Tamarit-Martinez C, Bernat-Just L, Bueno-Lopez C, Alambiaga-Caravaca A, Merino V, Lopez-Castellano A Pharmaceutics. 2024; 16(9).
PMID: 39339188 PMC: 11434902. DOI: 10.3390/pharmaceutics16091151.
Slota D, Jampilek J, Sobczak-Kupiec A Int J Mol Sci. 2024; 25(8).
PMID: 38673971 PMC: 11050486. DOI: 10.3390/ijms25084386.
Fauziah N, Safirah N, Rahmadani I, Hidayat M, Fadhilah N, Djide N Pharm Res. 2024; 41(5):967-982.
PMID: 38637438 DOI: 10.1007/s11095-024-03697-z.
Recent Advances in Antibacterial Coatings to Combat Orthopedic Implant-Associated Infections.
Akay S, Yaghmur A Molecules. 2024; 29(5).
PMID: 38474684 PMC: 10935003. DOI: 10.3390/molecules29051172.
Crisan A, Porfire A, Iurian S, Rus L, Lucacel Ciceo R, Turza A Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765129 PMC: 10537489. DOI: 10.3390/ph16091321.